Galderma
Innovative dermatology and skincare
- B2B
- B2C
- Publicly traded
- Manufacturing
- Multi-product
- Sales-led purchase
About Galderma
Development and delivery of advanced dermatological products and services including injectable aesthetics, skincare, and therapeutic solutions for patients.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001–10,000 employees
- Headquarters
- Zug, Switzerland
- Revenue
- €121MFY2025, filed accounts, INPI
- Website
- galderma.com
- linkedin.com/company/galderma-
Galderma in the news
- Galderma bespricht Auswirkungen der US-Zölle mit großen Einzelhändlern
Galderma is negotiating with US retailers regarding the impact of new tariffs.
- Galderma & Co: Mögliche Kaufgelegenheit für Schnäppchenjäger nach Aktienplatzierung
Galderma's stock has fallen due to a significant share sale, but historical trends suggest potential recovery.
- Galderma erzielt positive Studienergebnisse für Relfydess - Aktie in Grün
Galderma's Relfydess demonstrates sustained effectiveness for frown lines, boosting patient satisfaction and stock value.
- Galderma überwindet Verlust im GJ24; Umsatzanstieg -Am 06. März 2025 um 07:31 Uhr
Galderma has achieved profitability in 2024 with increased revenue.
- Galderma will nach Rekordjahr 2024 beschleunigt weiter wachsen
Galderma reports strong financial growth in 2024 and anticipates further acceleration in 2025.
Galderma at a glance
Galderma is a B2B/B2C company in the Pharmaceutical Manufacturing industry, headquartered in Zug, Switzerland.
Galderma has 5,001–10,000 employees.
Galderma's revenue is €121M (FY2025, filed accounts, INPI).
Selling to companies like Galderma?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies